Breast Cancer Therapeutics

Patent No. EP2618833 (titled "Breast Cancer Therapeutics") was filed by Imba Institut FR Molekulare Biotechnologie on Sep 22, 2011. The application was issued on May 2, 2018.

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

Company	Opposition Date	Representative
DEHMEL & BETTENHAUSEN PATENTANWALTE PARTMBB	Feb 1, 2019	RUCKERL
PATENTANWALTE ISENBRUCK BOSL HORSCHLER PARTG MBB	Jan 28, 2019	LAHRTZ

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

Date
Description

Get instant alerts for new documents

Oct 22, 2019
Communication to the parties concerning the termination of the opposition proceedings (opponent)
Oct 22, 2019
Communication to the parties concerning the termination of the opposition proceedings (opponent)
Oct 22, 2019
Communication to the parties concerning the termination of the opposition proceedings (proprietor)
Oct 15, 2019
Termination of the opposition proceedings with revocation of patent
Jul 15, 2019
Advice of delivery
Jul 12, 2019
Advice of delivery
Jul 11, 2019
Advice of delivery
Jul 11, 2019
Advice of delivery
Jul 8, 2019
Advice of delivery
Jul 8, 2019
Advice of delivery
Jul 5, 2019
Acknowledgement of a document
Jul 5, 2019
Acknowledgement of a document
Jul 5, 2019
Acknowledgement of a document
Jul 5, 2019
Decision revoking the European patent
Jul 5, 2019
Decision revoking the European patent
Jul 5, 2019
Decision revoking the European patent
Jul 3, 2019
Brief communication - Opposition proceedings
Jul 3, 2019
Brief communication - Opposition proceedings
Jun 27, 2019
(Electronic) Receipt
Jun 27, 2019
Request for revocation of patent
Feb 21, 2019
Communication of a notice of opposition and request to file observations
Feb 21, 2019
Notice of further oppositions to opponent(s)
Feb 21, 2019
Notice of further oppositions to opponent(s)
Feb 13, 2019
Communication of a notice of opposition - first information to patent proprietor
Feb 6, 2019
Communication of a notice of opposition - first information to patent proprietor
Feb 1, 2019
(Electronic) Receipt
Feb 1, 2019
Citation in opposition procedure
Feb 1, 2019
Non-patent literature cited during the opposition procedure
Feb 1, 2019
Non-patent literature cited during the opposition procedure
Feb 1, 2019
Non-patent literature cited during the opposition procedure
Feb 1, 2019
Non-patent literature cited during the opposition procedure
Feb 1, 2019
Non-patent literature cited during the opposition procedure
Feb 1, 2019
Non-patent literature cited during the opposition procedure
Feb 1, 2019
Non-patent literature cited during the opposition procedure
Feb 1, 2019
Non-patent literature cited during the opposition procedure
Feb 1, 2019
Non-patent literature cited during the opposition procedure
Feb 1, 2019
Non-patent literature cited during the opposition procedure
Feb 1, 2019
Non-patent literature cited during the opposition procedure
Feb 1, 2019
Non-patent literature cited during the opposition procedure
Feb 1, 2019
Notice of opposition
Feb 1, 2019
Notice of opposition
Feb 1, 2019
Patent document cited during the opposition procedure
Feb 1, 2019
Patent document cited during the opposition procedure
Jan 28, 2019
(Electronic) Receipt
Jan 28, 2019
Citation in opposition procedure
Jan 28, 2019
Citation in opposition procedure
Jan 28, 2019
Citation in opposition procedure
Jan 28, 2019
Citation in opposition procedure
Jan 28, 2019
Non-patent literature cited during the opposition procedure
Jan 28, 2019
Non-patent literature cited during the opposition procedure
Jan 28, 2019
Non-patent literature cited during the opposition procedure
Jan 28, 2019
Non-patent literature cited during the opposition procedure
Jan 28, 2019
Non-patent literature cited during the opposition procedure
Jan 28, 2019
Non-patent literature cited during the opposition procedure
Jan 28, 2019
Notice of opposition
Jan 28, 2019
Notice of opposition
Jan 28, 2019
Patent document cited during the opposition procedure
May 14, 2018
Transmission of the certificate for a European patent pursuant to Rule 74 EPC
Apr 6, 2018
Decision to grant a European patent
Mar 22, 2018
(Electronic) Receipt
Mar 22, 2018
Filing of the translations of the claims
Mar 22, 2018
French translation of claims
Mar 22, 2018
German translation of the claims
Mar 22, 2018
Letter accompanying subsequently filed items
Nov 24, 2017
Bibliographic data of the European patent application
Nov 24, 2017
Communication about intention to grant a European patent
Nov 24, 2017
Intention to grant (signatures)
Nov 24, 2017
Text intended for grant (clean copy)
Nov 24, 2017
Text intended for grant (sequence listing)
Nov 24, 2017
Text intended for grant (version for approval)
Oct 26, 2017
Processing of request for correction of text proposed for grant or third party observations (from 01-04-2012)
Oct 16, 2017
(Electronic) Receipt
Oct 16, 2017
Amended claims with annotations
Oct 16, 2017
Amended description with annotations
Oct 16, 2017
Claims
Oct 16, 2017
Description
Oct 16, 2017
Letter accompanying subsequently filed items
Oct 16, 2017
Request for correction/amendment of the text proposed for grant sent from 01.04.2012
Jun 6, 2017
Bibliographic data of the European patent application
Jun 6, 2017
Communication about intention to grant a European patent
Jun 6, 2017
Intention to grant (signatures)
Jun 6, 2017
Text intended for grant (clean copy)
Jun 6, 2017
Text intended for grant (sequence listing)
Jun 6, 2017
Text intended for grant (version for approval)
Feb 9, 2017
(Electronic) Receipt
Feb 9, 2017
Amended claims with annotations
Feb 9, 2017
Annex
Feb 9, 2017
Annex
Feb 9, 2017
Claims
Feb 9, 2017
Letter accompanying subsequently filed items
Feb 9, 2017
Non-patent literature cited during the examination procedure
Feb 9, 2017
Non-patent literature cited during the examination procedure
Feb 9, 2017
Non-patent literature cited during the examination procedure
Feb 9, 2017
Reply to communication from the Examining Division
Oct 17, 2016
Annex to the communication
Oct 17, 2016
Communication from the Examining Division
Oct 11, 2016
Examination started
Aug 26, 2013
(Electronic) Receipt
Aug 26, 2013
Amended claims filed after receipt of (European) search report
Aug 26, 2013
Amended claims with annotations
Aug 26, 2013
Amendments received before examination
Aug 26, 2013
Letter accompanying subsequently filed items
Jul 3, 2013
Notification on forthcoming publication of bibliographic data
May 2, 2013
Communication regarding comments on written opinion/amendment of application/payment of claims fee
Apr 26, 2013
Communication to designated inventor
Apr 26, 2013
Communication to designated inventor
Apr 23, 2013
Priority search results copy provided by EPO
Apr 3, 2013
Annexes to the international preliminary examination report
Apr 3, 2013
Copy of the international preliminary examination report
Mar 21, 2013
(Electronic) Receipt
Mar 21, 2013
Request for entry into the European phase
Feb 1, 2013
Information on entry into European phase
Jan 15, 2013
Annex to International preliminary examination report
Jan 15, 2013
International preliminary examination report
Jan 15, 2013
International preliminary examination report
Jan 15, 2013
International preliminary examination report - free text sheet
Jan 15, 2013
International preliminary examination report - free text sheet
Jan 15, 2013
International preliminary examination report - points I-VIII
Jan 15, 2013
International preliminary examination report - points I-VIII
Jan 15, 2013
Notification of documents sent to WIPO
Jan 15, 2013
Transmittal of International Preliminary Examination Report
Nov 29, 2012
PCT(IPEA): Amended sheet - claims
Nov 29, 2012
PCT(IPEA): Amended sheet - claims
Nov 29, 2012
Reply to communication PCT/IPEA/408
Nov 22, 2012
PCT(IPEA): Amended sheet - claims
Nov 22, 2012
PCT(IPEA): Amended sheet - claims
Nov 22, 2012
Reply to communication PCT/IPEA/408
Oct 23, 2012
Written opinion
Oct 23, 2012
Written opinion - free text sheet
Oct 23, 2012
Written opinion - points I-VIII
Aug 22, 2012
Notification of election of EPO
Aug 14, 2012
Amendments of documents (Article 19 PCT)
Jul 31, 2012
Notification of documents sent to WIPO
Jul 31, 2012
Notification of receipt of demand
Jul 25, 2012
Document concerning fees and payments
Jul 25, 2012
Non-patent literature cited during the examination procedure
Jul 25, 2012
Non-patent literature cited during the examination procedure
Jul 25, 2012
Non-patent literature cited during the examination procedure
Jul 25, 2012
PCT demand form
Jul 25, 2012
PCT(IPEA): Amended sheet - claims
Jul 25, 2012
PCT(IPEA): Amended sheet - claims
Jul 20, 2012
Document concerning fees and payments
Jul 20, 2012
Non-patent literature cited during the examination procedure
Jul 20, 2012
Non-patent literature cited during the examination procedure
Jul 20, 2012
Non-patent literature cited during the examination procedure
Jul 20, 2012
PCT demand form
Jul 20, 2012
PCT(IPEA): Amended sheet - claims
Jul 20, 2012
PCT(IPEA): Amended sheet - claims
Jun 21, 2012
Copy of the international search report
Jun 21, 2012
International publication of the international search report
Apr 20, 2012
Priority document (electronically transmitted)
Apr 11, 2012
Written opinion of the ISA, boxes No. I to VIII
Apr 11, 2012
Written opinion of the ISA, cover sheet
Apr 11, 2012
Written opinion of the ISA, supplemental box
Mar 29, 2012
Converted Sequence Listing
Mar 29, 2012
Published international application - A2
Sep 22, 2011
(Electronic) Receipt
Sep 22, 2011
Abstract
Sep 22, 2011
Claims
Sep 22, 2011
Description
Sep 22, 2011
Drawings
Sep 22, 2011
Priority document (RO-procedure)

EP2618833

IMBA INSTITUT FR MOLEKULARE BIOTECHNOLOGIE

Application Number: EP11758242A
Filing Date: Sep 22, 2011
Status: Revoked; Oct 18, 2019
Publication Date: May 2, 2018
External Links: Slate, Register , Google Patents

IP Verse

Breast Cancer Therapeutics

Patent Summary

Patent Family

Patent Oppositions (2)

Dossier Documents

EP2618833